Concepedia

Andreas Wunder

AW

Statistics

Publications

30

Citations

1.7K

H-Index

21

Active since

1995

Affiliations

Heidelberg University(Current)

German Cancer Research Center

Charité - Universitätsmedizin Berlin

University Medical Centre Mannheim

Boehringer Ingelheim (Germany)

Andreas Wunder is an author at Heidelberg University specializing in medicine, pharmacology, and neuroscience.

Publications per year

1995–2023

30

Publications

30

Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis

Andreas Wunder, Ulf Müller‐Ladner, Ernst H. K. Stelzer et al. · The Journal of Immunology · 2003 · 221 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2

Peter Vajkoczy, Mohammad Farhadi, Andreas Gäumann et al. · Journal of Clinical Investigation · 2002 · 221 citations · Full text

Medicine, Cancer Biology, Oncology +17

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2

Peter Vajkoczy, Mohammad Farhadi, Andreas Gäumann et al. · Journal of Clinical Investigation · 2002 · 178 citations

Medicine, Cancer Biology, Oncology +17

In vivo imaging of protease activity in arthritis: A novel approach for monitoring treatment response

Andreas Wunder, Ching‐Hsuan Tung, Ulf Müller‐Ladner et al. · Arthritis & Rheumatism · 2004 · 159 citations

Medicine, Pathology, Pharmacology +17

The loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats

G. Stehle, H. Sinn, Andreas Wunder et al. · Anti-Cancer Drugs · 1997 · 103 citations

Pharmacy, Pharmaceutics, Pharmacology +14

1–5 of 30